---
title: First Slide
image: MAPA VACUNAS ING v3.png
---

# The route of vaccines

The Route of Vaccines is a cartographic representation of the purchase agreements entered into by the pharmaceutical companies that produce the vaccines that have been administered in Mexico. These 8 companies have sold 9.2 billion doses worldwide. **Pfizer** is the company with the most doses sold in the group (3.366 billion doses in 100 contracts with 55 countries). It is followed by **Serum Institute of India** (2.135 billion doses in 40 contracts with 31 countries), **AstraZeneca** (1.256 billion doses in 36 contracts with 33 countries), and **Moderna** (1.036 billion doses in 33 contracts with 22 countries). Pfizer, AstraZeneca, Moderna, and Janssen have their primary destination in the United States, whereas Serum Institute of India has India; Sinovac has China; Sputnik V has Iran, in addition to Russia; and Cansino has Mexico. **Pfizer, Moderna, and Janssen have sent more than 60% of their total doses to the United States, Canada, and Europe.** Sinovac and Sputnik V have sent at least half their doses to Asia and AstraZeneca has sent a third of its doses to Asia and a third to Latin America as its leading destinations. Latin America has received 1.326 billion doses from these 8 companies. Eighteen countries have purchase agreement with the companies, the top destinations being Brazil, Mexico, and Peru; Brazil has acquired nearly half of these doses. The pharmaceutical companies with most doses sold in the region are Pfizer, AstraZeneca, and Sinovac.

<a class="btn btn-secondary" href="https://poderlatam.org/wp-content/uploads/2022/09/MAPA-VACUNAS-ING-v3.png" target="_blank">Full Screen Map</a>
<br>
